Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative
暂无分享,去创建一个
M. Sprangers | G. Meijer | M. V. van Oijen | P. Siersema | G. Tienhoven | C. Punt | V. Lemmens | J. V. van Sandick | C. V. van Eijck | H. Stockmann | D. Sommeijer | M. Koopman | H. Verkooijen | L. V. van de Poll-Franse | J. Ijzermans | M. Bruno | G. Nieuwenhuijzen | M. Berbée | P. Coene | J. D. de Groot | I. de Hingh | J. Dekker | F. Erdkamp | J. Ijzermans | M. Los | R. Rietbroek | A. Schiphorst | M. Tjin-A-Ton | A. V. D. Velden | W. J. Vles | David D. E. Zimmerman | M. Besselink | H. V. van Laarhoven | H. Bloemendal | M. I. van Berge Henegouwen | M. Hulshof | J. Groot | M. Slingerland | O. Busch | I. Molenaar | G. van Tienhoven | M. Spaander | I. Molenaar | L. V. van Rijssen | T. Rozema | L. B. Rijssen | J. Wilmink | J. Ruurda | G. Vink | N. V. van Grieken | J. de Vos-Geelen | V. Coupé | L. Kwakkenbos | I. Q. Molenaar | M. D. de Noo | D. Zimmerman | R. R. Coebergh van den Braak | L. Poll-Franse | M. Elferink | J. Sandick | W. Roeloffzen | M. Burgmans | I. Hingh | J. Vos-Geelen | M. Strijker | W. V. van Grevenstein | W. V. Grevenstein | I. Hingh | A. V. D. van der Velden | G. Nieuwenhuijzen | M. V. Oijen | L. Timmermans | J. V. van Kleef | H. Laarhoven | W. Roeloffzen | H. Schipper | M. Verhaar | R. V. D. Braak | N. Grieken | C. Eijck | R. R. J. Coebergh van den Braak | I. D. de Hingh | J. J. V. Kleef | M. D. Noo | M. B. Henegouwen | L. B. V. Rijssen
[1] H. Verspaget,et al. The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands , 2017 .
[2] Simon Tavaré,et al. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance , 2016, Nature Genetics.
[3] E. Kuipers,et al. Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research , 2016, Acta oncologica.
[4] R. van Hillegersberg,et al. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[5] Iris D. Nagtegaal,et al. The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review , 2016, Virchows Archiv.
[6] Erik Schultes,et al. The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.
[7] R. Gibbs,et al. Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.
[8] S. Ramsey,et al. Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. , 2016, Journal of the National Cancer Institute.
[9] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[10] Kathleen A Cronin,et al. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. , 2014, Cancer.
[11] J. Chabot,et al. Limitations of ACS-NSQIP in Reporting Complications for Patients Undergoing Pancreatectomy: Underscoring the Need for a Pancreas-Specific Module , 2014, World Journal of Surgery.
[12] Joel Cutcher-Gershenfeld,et al. Precompetitive consortia in biomedicine—how are we doing? , 2013, Nature Biotechnology.
[13] V. Lemmens,et al. The Dutch surgical colorectal audit. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[14] Vincenzo Canzonieri,et al. An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank , 2013, BMC medical ethics.
[15] J. Coebergh,et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. , 2011, European journal of cancer.
[16] Jon Nicholl,et al. Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design , 2010, BMJ : British Medical Journal.
[17] Jacques Ferlay,et al. NORDCAN – a Nordic tool for cancer information, planning, quality control and research , 2010, Acta oncologica.
[18] C. Ko,et al. Does Surgical Quality Improve in the American College of Surgeons National Surgical Quality Improvement Program: An Evaluation of All Participating Hospitals , 2009, Annals of surgery.
[19] V. Devita. The clinical trials system is broken , 2008, Nature Clinical Practice Oncology.
[20] D. Gandara,et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] R. Holcombe,et al. Informed consent for clinical trials: a comparative study of standard versus simplified forms. , 1998, Journal of the National Cancer Institute.
[22] J. Jager,et al. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. , 1993, British Journal of Cancer.
[23] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[24] P. Levine,et al. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.
[25] G. Kazemier,et al. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[26] S. Kaasa,et al. The length of consent documents in oncological trials is doubled in twenty years. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[28] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .